IPO Profile: Aeglea Bio was the only VC-backed company to launch an IPO in April
The Austin, Texas-based drug developer raised $54.7 million from investors prior to its April 7 IPO on th Nasdaq
1 May 2016•2 mins read
The Austin, Texas-based drug developer raised $54.7 million from investors prior to its April 7 IPO on th Nasdaq
